Streptococcus pyogenes causes a wide variety of infections in individu
als of all ages in most countries of the world. Because of the frequen
cy with which these infections occur, physicians are quite familiar wi
th the diversity of clinical presentations associated with the Group A
streptococcus. Yet in the late 1980's, a severe form of streptococcal
infection, the Streptococcal Toxic Shock Syndrome, emerged and has pe
rsisted for the last 10 years. This syndrome is associated with invasi
ve soft tissue infections and the early onset of shock and organ failu
re. The purpose of this paper is to briefly describe the epidemiologic
and clinical features of the Streptococcal Toxic Shock Syndromes and
to emphasize the role that toxins produced by S. pyogenes play in the
pathogenesis of this disease.